Last updated: October 19, 2026
How to Send Useful Feedback
For a correction, identify the article URL, the specific statement or table row, and why the information appears inaccurate or outdated. If you have a public FDA, DailyMed, CMS, manufacturer or peer-reviewed source, include a link rather than pasting private medical records.
You may also use the form for questions about the site’s editorial standards, inaccurate reviewer attribution, accessibility, privacy or other technical problems. A submission may be reviewed without an individualized reply.
| Question | Appropriate route |
|---|---|
| Incorrect SemaGLP claim | SemaGLP contact form with article URL and evidence |
| Personal treatment or adverse effect | Prescriber or pharmacist; urgent care when necessary |
| Order, refund or shipping complaint | The pharmacy or outside provider that accepted the transaction |
| Questionable online pharmacy license | State board of pharmacy / FDA reporting channel |
| Website data privacy question | SemaGLP contact form under Privacy request |
Send a Message to SemaGLP
Only editorial and site-related information belongs in this form. An email address is requested to allow a reply when appropriate. Sending a message does not create medical care or guarantee an individual response.
Report a Product or Labeling Error
Semaglutide articles can become outdated when brand names, dosage forms, indications, product warnings or approval records change. In particular, readers should distinguish Ozempic pills from injections, Wegovy standard products from Wegovy HD, and U.S. FDA approvals from foreign marketing authorizations.
If you report an inaccurate claim, provide the official record and relevant date when possible. A product’s FDA authorization and the question of whether a local pharmacy can fill it today are separate.
Pharmacy and Online-Seller Concerns
SemaGLP does not operate or supervise outside pharmacies. We welcome notice of incorrect statements made on our own pages about pharmacy licensing, prescription requirements or commercial relationships, but cannot investigate a patient’s individual transaction or intervene in a disputed third-party purchase.
If the concern is a suspicious or potentially counterfeit medicine, stop relying on the seller’s promotional assurances and consult the dispensing pharmacist or relevant authorities. Use official FDA and state board channels for appropriate reporting.
Editorial and Medical-Review Questions
Our Editorial Policy explains factual corrections and source choice. The Medical Review Process and reviewer standards describe how professional contributions should be represented, without claiming that every page has individual clinician approval.
You can flag a review date or named attribution you believe is unsupported. SemaGLP will evaluate evidence without promising any particular editorial conclusion.
Privacy Requests and What Not to Send
The contact form collects an email address and your message, and optionally a name, article URL and public source URL. Please do not include a birth date, address, insurance number, health history, prescription copy, lab results, card information, passwords or another person’s details.
Requests about personal information submitted to this site can use the privacy topic in the form. The Privacy Policy describes the general processing context and relevant rights.
No Emergency, Prescription or Order Support
This inbox cannot diagnose symptoms, give injection instructions, choose a dose, renew a prescription, calculate individual eligibility or promise pharmacy inventory. Our contact system is for website correspondence only; filling out the form creates no clinician–patient relationship.
For urgent symptoms seek appropriate medical help promptly. For an existing pharmacy or telehealth order, contact the business that accepted the prescription or payment.